Exact Mass: 339.1318

Exact Mass Matches: 339.1318

Found 97 metabolites which its exact mass value is equals to given mass value 339.1318, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetraphenylphosphonium

Tetraphenylphosphonium

C24H20P+ (339.1303)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D000970 - Antineoplastic Agents

   

RAD51 inhibitor B02

RAD51 inhibitor B02

C22H17N3O (339.1372)


   

5-Hydroxytryptophol glucuronide

(2R,3R,4S,5S,6R)-2-{[3-(2-hydroxyethyl)-1H-indol-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H21NO7 (339.1318)


5-Hydroxytryptophol glucuronide (GTOL) is the major excretion form of 5-hydroxytryptophol (5-HTOL), a minor serotonin metabolite under normal conditions. Because the concentration of 5-HTOL is markedly increased following consumption of alcohol, measurement of 5-HTOL is used as a sensitive biomarker for detection of recent alcohol intake. PMID: 15664340. 5-Hydroxytryptophol glucuronide provided higher diagnostic specificity and sensitivity than 5-hydroxytryptophol. PMID: 17112495. 5-Hydroxytryptophol glucuronide (GTOL) is the major excretion form of 5-hydroxytryptophol (5-HTOL), a minor serotonin metabolite under normal conditions. Because the concentration of 5-HTOL is markedly increased following consumption of alcohol, measurement of 5-HTOL is used as a sensitive biomarker for detection of recent alcohol intake. PMID: 15664340

   

7-Hydroxygliclazide

N-{5-hydroxy-octahydrocyclopenta[c]pyrrol-2-yl}-N-(4-methylbenzenesulphonyl)carbamimidic acid

C15H21N3O4S (339.1253)


7-Hydroxygliclazide is only found in individuals that have used or taken Gliclazide. 7-Hydroxygliclazide is a metabolite of Gliclazide. 7-hydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

6-Hydroxygliclazide

N-{4-hydroxy-octahydrocyclopenta[c]pyrrol-2-yl}-N-(4-methylbenzenesulphonyl)carbamimidic acid

C15H21N3O4S (339.1253)


6-Hydroxygliclazide is only found in individuals that have used or taken Gliclazide. 6-Hydroxygliclazide is a metabolite of Gliclazide. 6-hydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

Methylhydroxygliclazide

N-[4-(Hydroxymethyl)benzenesulphonyl]-n-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidic acid

C15H21N3O4S (339.1253)


Methylhydroxygliclazide is only found in individuals that have used or taken Gliclazide. Methylhydroxygliclazide is a metabolite of Gliclazide. Methylhydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

N(G)-Nitroarginine-4-nitroanilide

2-amino-5-{[amino(nitroamino)methylidene]amino}-N-(4-nitrophenyl)pentanamide

C12H17N7O5 (339.1291)


   

Panipenem

3-[(1-ethanimidoylpyrrolidin-3-yl)sulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C15H21N3O4S (339.1253)


   

Tox21_302226

BENZENEACETIC ACID, ALPHA-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.0(SUP 2,4))NON-7-YL ESTER, HYDROCHLORIDE, (7(S)-(1-.ALPHA.,2-.BETA.,4-.BETA.,5-.ALPHA.,7-.BETA.))-

C17H21NO4.HCl (339.1237)


   
   
   

3-(2-hydroxyethyl)-1H-indole-5-O-beta-D-glucopyranoside

3-(2-hydroxyethyl)-1H-indole-5-O-beta-D-glucopyranoside

C16H21NO7 (339.1318)


   
   

Maybridge4_004251

Maybridge4_004251

C18H17N3O4 (339.1219)


   

MCULE-2604512160

MCULE-2604512160

C18H17N3O4 (339.1219)


   

[[1-amino-3-(5-methyl-2-oxo-1,3-benzoxazol-3-yl)propylidene]amino] benzoate

[[1-amino-3-(5-methyl-2-oxo-1,3-benzoxazol-3-yl)propylidene]amino] benzoate

C18H17N3O4 (339.1219)


   
   

makomotindoline

makomotindoline

C16H21NO7 (339.1318)


   

(4S,5S,11S)-5-O-(beta-D-Xylopyranosyl)streptazolin

(4S,5S,11S)-5-O-(beta-D-Xylopyranosyl)streptazolin

C16H21NO7 (339.1318)


   
   
   
   
   

Tox21_302226

BENZENEACETIC ACID, ALPHA-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.0(SUP 2,4))NON-7-YL ESTER, HYDROCHLORIDE, (7(S)-(1-.ALPHA.,2-.BETA.,4-.BETA.,5-.ALPHA.,7-.BETA.))-

C17H22ClNO4 (339.1237)


   
   
   
   
   
   
   

N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)-Benzenesulfonamide

N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)-Benzenesulfonamide

C15H21N3O4S (339.1253)


   

N-((4-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

N-((4-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

C15H21N3O4S (339.1253)


   

N-((5-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

N-((5-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

C15H21N3O4S (339.1253)


   

N-oxide gliclazide

N-oxide gliclazide

C15H21N3O4S (339.1253)


   

JWH 203

2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C21H22ClNO (339.139)


   

JWH203-3 Chrophenyl isomer

JWH203-3 Chrophenyl isomer

C21H22ClNO (339.139)


   

JWH 203 4-chlorophenyl isomer

JWH 203 4-chlorophenyl isomer

C21H22ClNO (339.139)


   

4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazineethanol

4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazineethanol

C19H21N3OS (339.1405)


   

N-BOC-4-(P-CHLOROPHENYL)-4-PIPERIDINE CARBOXYLIC ACID

N-BOC-4-(P-CHLOROPHENYL)-4-PIPERIDINE CARBOXYLIC ACID

C17H22ClNO4 (339.1237)


   

Poly(oxy-1,2-ethandiyl), alpha-decyl-omega-hydroxy-, phosphat, Kaliumsalz

Poly(oxy-1,2-ethandiyl), alpha-decyl-omega-hydroxy-, phosphat, Kaliumsalz

C12H29KO6P+ (339.1339)


   

BOC--(2-CHLORBENZYL)-DL-PRO-OH

BOC--(2-CHLORBENZYL)-DL-PRO-OH

C17H22ClNO4 (339.1237)


   

BOC--(3-CHLORBENZYL)-DL-PRO-OH

BOC--(3-CHLORBENZYL)-DL-PRO-OH

C17H22ClNO4 (339.1237)


   

Hydroxy Bendamustine

Hydroxy Bendamustine

C16H22ClN3O3 (339.135)


   

cocaine Hcl

Cocaine hydrochloride

C17H22ClNO4 (339.1237)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Panipenem

Panipenem

C15H21N3O4S (339.1253)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

4-Ethyl-3-methyl-1-phenyl-1H-indeno[1,2-b]pyrazolo[4,3-e]pyridin-5-one

4-Ethyl-3-methyl-1-phenyl-1H-indeno[1,2-b]pyrazolo[4,3-e]pyridin-5-one

C22H17N3O (339.1372)


   

4-(4-methoxyphenyl)-2,2:6,2-terpyridine

4-(4-methoxyphenyl)-2,2:6,2-terpyridine

C22H17N3O (339.1372)


   

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-chlorobenzyl)pyrrolidine-2-carboxylic acid

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-chlorobenzyl)pyrrolidine-2-carboxylic acid

C17H22ClNO4 (339.1237)


   

3-[(2-hydroxyethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile

3-[(2-hydroxyethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile

C17H17N5O3 (339.1331)


   

N6-Trifluoroacetyl-L-lysyl-L-proline

N6-Trifluoroacetyl-L-lysyl-L-proline

C13H20F3N3O4 (339.1406)


   

1H-Benz[de]isoquinoline-1,3(2H)-dione,5-nitro-2-[2-(1-pyrrolidinyl)ethyl]-

1H-Benz[de]isoquinoline-1,3(2H)-dione,5-nitro-2-[2-(1-pyrrolidinyl)ethyl]-

C18H17N3O4 (339.1219)


   

3-Fluoro-N-1H-indol-5-YL-5-morpholin-4-ylbenzamide

3-Fluoro-N-1H-indol-5-YL-5-morpholin-4-ylbenzamide

C19H18FN3O2 (339.1383)


   

Benzoic acid [[1-(4-nitrophenyl)-4-piperidinylidene]amino] ester

Benzoic acid [[1-(4-nitrophenyl)-4-piperidinylidene]amino] ester

C18H17N3O4 (339.1219)


   

3-(4-methoxyphenyl)-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide

3-(4-methoxyphenyl)-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide

C19H21N3OS (339.1405)


   

3-(Hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

3-(Hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

C16H22NO5P (339.1236)


   

N(G)-Nitroarginine-4-nitroanilide

2-amino-5-{[amino(nitroamino)methylidene]amino}-N-(4-nitrophenyl)pentanamide

C12H17N7O5 (339.1291)


   

Panipenem

3-[(1-ethanimidoylpyrrolidin-3-yl)sulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C15H21N3O4S (339.1253)


   

3,5-dihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-(3-methylbut-2-en-1-yl)phenolate

3,5-dihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-(3-methylbut-2-en-1-yl)phenolate

C20H19O5- (339.1232)


   

N(2),N(5)-dibenzoyl-L-ornithinate

N(2),N(5)-dibenzoyl-L-ornithinate

C19H19N2O4- (339.1345)


   

7-Hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-5-olate

7-Hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-5-olate

C20H19O5- (339.1232)


   

2-[1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethyl dihydrogen phosphate

2-[1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethyl dihydrogen phosphate

C14H20N4O4P+ (339.1222)


   

sophoraflavanone B(1-)

sophoraflavanone B(1-)

C20H19O5- (339.1232)


Conjugate base of sophoraflavanone B arising from deprotonation of the 7-hydroxy group.

   

(2S)-2-amino-N-[(2S)-1-[[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]amino]-1-oxopropan-2-yl]propanamide

(2S)-2-amino-N-[(2S)-1-[[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]amino]-1-oxopropan-2-yl]propanamide

C16H22ClN3O3 (339.135)


D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones

   

(1R,2R,3S,5S)-3-(benzoyloxy)-2-(methoxycarbonyl)-8-methyl-8-azoniabicyclo[3.2.1]octane chloride

(1R,2R,3S,5S)-3-(benzoyloxy)-2-(methoxycarbonyl)-8-methyl-8-azoniabicyclo[3.2.1]octane chloride

C17H22ClNO4 (339.1237)


   

N-[(E)-1-(3-Acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide

N-[(E)-1-(3-Acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide

C18H17N3O4 (339.1219)


   

8-Benzyl-4-pyridin-2-yl-1-thia-4,8-diazaspiro[4.5]decan-3-one

8-Benzyl-4-pyridin-2-yl-1-thia-4,8-diazaspiro[4.5]decan-3-one

C19H21N3OS (339.1405)


   
   

4-[4-[(4-Methoxyphenyl)methyl]-1-piperidinyl]thieno[2,3-d]pyrimidine

4-[4-[(4-Methoxyphenyl)methyl]-1-piperidinyl]thieno[2,3-d]pyrimidine

C19H21N3OS (339.1405)


   

(5E)-5-[(1-benzyl-2,5-dimethylpyrrol-3-yl)methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one

(5E)-5-[(1-benzyl-2,5-dimethylpyrrol-3-yl)methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one

C19H21N3OS (339.1405)


   

(2R,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2R,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.1405)


   

(2S,3S,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3S,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.1405)


   

(2S,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.1405)


   

(2S,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.1405)


   

(2S,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2S,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.1405)


   

3-(benzotriazol-1-yl)-N-[(E)-(2-hydroxy-5-methoxyphenyl)methylideneamino]propanamide

3-(benzotriazol-1-yl)-N-[(E)-(2-hydroxy-5-methoxyphenyl)methylideneamino]propanamide

C17H17N5O3 (339.1331)


   

(2R,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2R,3R,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.1405)


   

(2R,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

(2R,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidine-2-carbonitrile

C19H21N3OS (339.1405)


   
   
   
   
   
   

desmethylxanthohumol(1-)

desmethylxanthohumol(1-)

C20H19O5 (339.1232)


A phenolate anion that is the conjugate base of xanthohumol, obtained by deprotonation of the 1-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

5-Hydroxytryptophol glucuronide

5-Hydroxytryptophol glucuronide

C16H21NO7 (339.1318)


   

Methylhydroxygliclazide

Methylhydroxygliclazide

C15H21N3O4S (339.1253)


   

7-Hydroxygliclazide

7-Hydroxygliclazide

C15H21N3O4S (339.1253)


   

O-hydroxy(phenyl)phosphinoyl ecgonine methyl ester

O-hydroxy(phenyl)phosphinoyl ecgonine methyl ester

C16H22NO5P (339.1236)


The O-hydroxy(phenyl)phosphinoyl derivative of ecgonine methyl ester.

   

Hydroxytryptophol glucuronide

Hydroxytryptophol glucuronide

C16H21NO7 (339.1318)


   

HJC0197

HJC0197

C19H21N3OS (339.1405)


HJC0197 is a potent Epac1 (exchange protein directly activated by cAMP 1) and Epac2 (IC50=5.9 μM for Epac2) antagonist. HJC0197 selectively blocks cAMP-induced Epac activation. HJC0197 inhibits Epac1-mediated Rap1-GDP exchange activity at 25 μM in the presence of equal concentration of cAMP[1].

   

SIBA

SIBA

C14H21N5O3S (339.1365)


SIBA (5'-Isobutylthioadenosine) is a transmethylation inhibitor (SAH (HY-19528) analogue), with potent anti-proliferative activity. SIBA reversibly inhibits the production of HSV-1 by blocking methylation, specifically by blocking the 5' end-capping of viral mRNA. SIBA also inhibits the growth of tumour cells in vitro and metastatic spread in vivo. SIBA can be used in cancer, HSV-1 infection and anti-malaria studies[1][2][3].

   

VU6010572

VU6010572

C20H18FNO3 (339.1271)


VU6010572 is a potent and selective mGlu3 negative allosteric modulator with IC50 of 245 nM. VU6010572 is highly CNS penetrant[1][2].

   

4-(1h-indol-3-yl)-6-(1h-indol-3-ylmethyl)pyridin-3-ol

4-(1h-indol-3-yl)-6-(1h-indol-3-ylmethyl)pyridin-3-ol

C22H17N3O (339.1372)


   

methyl 3-{[1-(1-hydroxyethyl)-9h-pyrido[3,4-b]indol-3-yl]formamido}prop-2-enoate

methyl 3-{[1-(1-hydroxyethyl)-9h-pyrido[3,4-b]indol-3-yl]formamido}prop-2-enoate

C18H17N3O4 (339.1219)


   

(4s,5s,6z,11s)-6-ethylidene-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-oxa-1-azatricyclo[5.3.1.0⁴,¹¹]undec-7-en-2-one

(4s,5s,6z,11s)-6-ethylidene-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-oxa-1-azatricyclo[5.3.1.0⁴,¹¹]undec-7-en-2-one

C16H21NO7 (339.1318)


   

methyl (2z)-3-({1-[(1r)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

methyl (2z)-3-({1-[(1r)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

C18H17N3O4 (339.1219)


   

methyl (2z)-3-({1-[(1s)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

methyl (2z)-3-({1-[(1s)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

C18H17N3O4 (339.1219)


   

methyl 3-({1-acetyl-9h-pyrido[3,4-b]indol-3-yl}formamido)propanoate

methyl 3-({1-acetyl-9h-pyrido[3,4-b]indol-3-yl}formamido)propanoate

C18H17N3O4 (339.1219)